期刊文献+

良性前列腺增生患者血清PSA与体重指数、年龄的关系——附444例检测分析 被引量:5

下载PDF
导出
摘要 目的:探讨BPH患者血清前列腺特异性抗原(prostate specific antigen,PSA)与体重指数、年龄之间的关系。方法:检测444例前列腺增生患者的血清总前列腺特异性抗原(total prostate specific antigen,tPSA)、游离前列腺特异性抗原(free prostate specific an-tigen,fPSA),计算fPSA与tPSA的比值(fPSA/tPSA),并根据体重指数将患者分为正常组、超重组及肥胖组,分析PSA与体重指数及年龄的关系。结果:444例患者的年龄与tPSA、fP-SA呈正相关(r值分别为0.459和0.229,均为P<0.01),体重指数与tPSA、fPSA呈负相关(r值分别为-0.357和-0.378,均为P<0.01);体重指数、年龄与fPSA/tPSA均无相关性(均为P>0.05)。结论:体重指数、年龄对BPH患者尤其是肥胖患者的血清tPSA和fPSA水平有一定的影响,但对fPSA/tPSA比值影响不大。
出处 《新医学》 2009年第1期35-37,共3页 Journal of New Medicine
  • 相关文献

参考文献9

  • 1邓春华,罗道升.良性前列腺增生的临床和相关检查[J].新医学,2006,37(11):762-763. 被引量:10
  • 2WHO EXPERT CONSULTATION. Appropriate body mass index for Asian populations and its implications for policy and intervention strategies [J]. Lancet, 2004, 363 (9403) : 157-163.
  • 3黄伟刚,赖建生,林津,许胜利.健康男性与前列腺疾病患者的血清前列腺特异抗原水平差异[J].新医学,2004,35(9):551-552. 被引量:3
  • 4李亚南,毕向军,陈晓清,张晓峰,肖丽萍,余新沛,刘岗,杨明常,宋骤,刘坚.单纯前列腺上皮内瘤临床和病理特征分析——附23例报告[J].新医学,2008,39(2):80-82. 被引量:6
  • 5BAILLARGEON J, POLLOCK B H, KRISTAL A R, et al. The association of body mass index and prostate-specific antigen in a population-based study [ J]. Cancer, 2005, 103 (5): 1092-1095.
  • 6OCHIAI A, FRITSCHE H A, AND BABAIAN R J. Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer [ J]. Urology, 2005, 66 (4) : 819-823.
  • 7WHITTMORE A S, CIRILLO P M, FELDMAN D, et al. Prostate specific antigen levels in young adulthood predict prostate cancer risk : results from a cohort of black and white Americans[J]. J Urol, 2005, 174(3) : 872-876.
  • 8BANEZ L L, HAMILTON R J, PARTIN A W, et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer[ J]. JAMA, 2007,298 (19): 2275-2280.
  • 9AMLING C, RIFFENBURGH R, SUN L, et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy[ J]. J Clin Oncol, 2004, 22 (3) : 439- 445.

二级参考文献9

  • 1方友强,高新.生物标记物早期诊断前列腺癌的研究进展[J].新医学,2005,36(5):309-310. 被引量:3
  • 2Oesterling JE, Jacobsen S J, Klee GG, et al. Free, complexed and total serum prostate specific antigen: The establishment of appropriate reference ranges for their concentrations and ratios. J Urol, 1995, 154(3): 1090-1095.
  • 3HELPAP B. The significance of the P504S expression pattern of high-grade prostatic intraepithelial neoplasia (HGPIN) with and without adenocarcinoma of the prostate in biopsy and radical prostatectomy specimens[J]. Virchows Arch, 2006, 448 (4) : 480- 484.
  • 4LOEB S, GONZALEZ C M, ROEHL K A, et al. Pathological characteristics of prostate cancer detected through prostate specific antigen based screening[J]. J Urol, 2006, 175 (3 Pt 1 ) : 902- 906.
  • 5YANG W J, LEE D H, CHUNG B H, et al. Detection rate of prostate cancer on biopsy according to serum prostate-specific antigen in Korean men: a multicenter study[ J ]. Urology, 2006, 67 (2) : 333-336.
  • 6DE MATTEIS M, POGGI C, DE MARTINO A, et al. Repeat biopsy in patients with initial diagnosis of PIN [ J]. Radiol Med (意大利文),2005,110(3):190-198.
  • 7KAWAI M, OKAJIMA K, KOBAYASHI K, et al. Combined use of PSA density and free to total PSA ratio for cancer detection from patients with PSA elevations [ J ]. Hinyokika Kiyo (日文 ), 2006, 52 (2): 113-117.
  • 8傅雷,王自正,王书奎,孙君江.游离与总前列腺特异抗原比值临床应用[J].中华检验医学杂志,2000,23(1):40-40. 被引量:26
  • 9周利群,陈为民,那彦群,黄有媛,冯陶,郝金瑞,潘柏年,薛兆英,顾方六,郭应禄.良性前列腺增生患者血清PSA与年龄变化的关系[J].中华泌尿外科杂志,2002,23(5):293-295. 被引量:38

共引文献14

同被引文献38

  • 1李飞宇,王霄英,丁建平,周良平,肖江喜,蒋学祥.良性前列腺增生的MRS与血清PSA、PSAD相关性初步研究[J].中国医学影像技术,2004,20(8):1164-1167. 被引量:7
  • 2朱生才,刘明,王建业.血清前列腺特异抗原4~10μg/L的前列腺癌“灰区”的诊断和治疗[J].中华老年医学杂志,2006,25(4):269-271. 被引量:10
  • 3李培军,张祥华,郭利君,那彦群.血清PSA与良性前列腺增生临床病理的相关性研究[J].中华泌尿外科杂志,2006,27(6):421-423. 被引量:14
  • 4ORNSTEIN D K,RAYFORD W,FUSARO V A,et al.Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml[J].J Urol,2004,172(4 Pt 1):1302-1305.
  • 5SHEIKH M,AL-SAEED O,KEHINDE E O,et al.Utility of volume adjusted prostate specific antigen density in the diagnosis of prostate cancer in Arab men[J].Int Urol Nephrol,2005,37(4):721-726.
  • 6OESTERLING J E,TEKCHANDANI A H,MARTIN S K,et al.The periurethral glands do not significantly influence the serum prostate specific antigen concentration[J].J Urol,1996,155(5):1658-1660.
  • 7IRANI J,SALOMON L,SOULI(E) M,et al.Urinary/serum prostate-specific antigen ratio:comparison with free/total serum prostate-specific antigen ratio in improving prostate cancer detection[J].Urology,2005,65(3):533-537.
  • 8CATALONA W J,SOUTHWICK P C,SLAWIN K M,et al.Comparison of percent free PSA,PSA density,and age-specific PSA cutoffs for prostate cancer detection and staging[J].Urology,2000,56(2):255-260.
  • 9ASLAN G,IRER B,KEFI A,et al.The value of PSA,free-to-total PSA ratio and PSA density in the prediction of pathologic stage for clinically localized prostate cancer[J].Int Urol Nephrol,2005,37(3):511-514.
  • 10那彦群.中华医学会泌尿外科学分会(cUA)良性前列腺增生临床诊治指南[M].北京:人民卫生出版社,2009:1-27.

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部